Wednesday, February 10, 2010, 8:09pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

BioCryst Pharmaceuticals, Inc. (BCRX)

At 5:00AM SGT: 6.25 USD   0.00 (0.00%)  
 MORE ON BCRX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 BioCryst Pharmaceuticals, Inc. (NGM:BCRX) Delayed quote dataEdit
Last Trade:6.25 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:6.25
Open:N/A
Bid:5.56 x 100
Ask:6.36 x 3000
1y Target Est:15.00
Day's Range:N/A - N/A
52wk Range:1.15 - 13.47
Volume:0
Avg Vol (3m):1,730,510
Market Cap:242.64M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add BCRX to Portfolio   Download Data

 HEADLINES 
•Traders Send Select Stem Cell Shares Soaring
Indie Research (Mon, Feb 8)
•New Star Analyst Rankings for BioCryst Pharmaceuticals, Inc.
StarMine (Sun, Feb 7)
•Big Pharma's Shot In The Arm
at CNBC (Sat, Feb 6)
•BioCryst Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Feb 5)
•BioCryst 4Q profit rises on flu drug sales
AP (Fri, Feb 5)
•Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
Indie Research (Thu, Feb 4)
•BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Thu, Feb 4)
•UPDATE - BioCryst Q4 results top Street on flu drug sales
at Reuters (Thu, Feb 4)
•Q4 2009 BioCryst Pharmaceuticals Earnings Release - Time Not Supplied
CCBN (Thu, Feb 4)
•BioCryst Reports Fourth Quarter and Full Year 2009 Financial Results and Provides Corporate Update
PR Newswire (Thu, Feb 4)
More Headlines for BCRX...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.78
EPS Est (in 2 years) (Dec-10) :0.02
Avg Rec (current)*:2.8
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices